{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T16:16:10Z","timestamp":1776010570214,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,17]],"date-time":"2013-11-17T00:00:00Z","timestamp":1384646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00277-013-1945-4","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T04:38:34Z","timestamp":1384576714000},"page":"57-64","source":"Crossref","is-referenced-by-count":17,"title":["Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis"],"prefix":"10.1007","volume":"93","author":[{"given":"Sigrid","family":"Machherndl-Spandl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"B\u00f6sm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Germing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ch.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nachtkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Reinecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Wimazal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"M\u00fcllauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Sotlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. P.","family":"Horny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"T\u00fcchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Valent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,17]]},"reference":[{"key":"1945_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT et al (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189\u2013199","journal-title":"Br J Haematol"},{"key":"1945_CR2","unstructured":"Brunning RD, Bennet JM, Flandrin G et al. (2001) Myelodysplastic syndromes. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 61\u201374"},{"key":"1945_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2141.1989.tb06309.x","volume":"71","author":"A Pagliuca","year":"1989","unstructured":"Pagliuca A et al (1989) Myelofibrosis in primary myelodysplastic syndromes: a clinicomorphological study of 10 cases. Br J Haematol 71:499\u2013504","journal-title":"Br J Haematol"},{"key":"1945_CR4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/1097-0142(19910701)68:1<178::AID-CNCR2820680131>3.0.CO;2-Q","volume":"68","author":"K Ohyashiki","year":"1991","unstructured":"Ohyashiki K, Sasao I, Ohyashiki JH et al (1991) Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis. Cancer 68:178\u2013183","journal-title":"Cancer"},{"key":"1945_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF01698371","volume":"63","author":"GE Verhoef","year":"1991","unstructured":"Verhoef GE, De Wolf-Peeters C, Ferrant A et al (1991) Myelodysplastic syndromes with bone marrow fibrosis: a myelodysplastic disorder with proliferative features. Ann Hematol 63:235\u2013241","journal-title":"Ann Hematol"},{"key":"1945_CR6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.1992.tb01587.x","volume":"48","author":"H Maschek","year":"1992","unstructured":"Maschek H et al (1992) Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol 48:208\u2013214","journal-title":"Eur J Haematol"},{"key":"1945_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF01695890","volume":"66","author":"G Lambertenghi-Deliliers","year":"1993","unstructured":"Lambertenghi-Deliliers G, Annaloro C, Oriani A et al (1993) Prognostic relevance of histological findings on bone marrow biopsy in myelodysplastic syndromes. Ann Hematol 66:85\u201391","journal-title":"Ann Hematol"},{"issue":"4","key":"1945_CR8","first-page":"325","volume":"21","author":"D Marisavljevic","year":"2004","unstructured":"Marisavljevic D, Rolovic Z, Cemerikic V et al (2004) Myelofibrosis in primary myelodysplastic syndromes. Clin Biol Signif Med Oncol 21(4):325\u2013331","journal-title":"Clin Biol Signif Med Oncol"},{"key":"1945_CR9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2405030","volume":"22","author":"G Buesche","year":"2008","unstructured":"Buesche G, Teoman H, Wilczak W, Ganser A, Hecker H, Wilkens L, G\u00f6hring G, Schlegelberger B, Bock O, Georgi A, Kreipe H (2008) Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Leukemia 22:313\u2013322","journal-title":"Leukemia"},{"key":"1945_CR10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.2008.18.2246","volume":"27","author":"MG Della Porta","year":"2009","unstructured":"Della Porta MG, Malcovati L, Boveri E et al (2009) Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes. J Clin Oncol 27:754\u2013762","journal-title":"J Clin Oncol"},{"key":"1945_CR11","doi-asserted-by":"crossref","unstructured":"Santos FPS, Schlette E, Kantarjian H et al. (2009) Myelodysplastic syndrome with fibrosis: experience of a single-institution with 139 patients. Blood 114 (24): Abstract 2775","DOI":"10.1182\/blood.V114.22.2775.2775"},{"issue":"12","key":"1945_CR12","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.leukres.2007.05.010","volume":"31","author":"HP Horny","year":"2007","unstructured":"Horny HP, Sotlar K, Valent P (2007) Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes. Leuk Res 31(12):1609\u20131616","journal-title":"Leuk Res"},{"key":"1945_CR13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.18632\/oncotarget.185","volume":"1","author":"P Valent","year":"2010","unstructured":"Valent P, Orazi A, B\u00fcsche G, Schmitt-Gr\u00e4ff A, George TI, Sotlar K, Streubel B, Beham-Schmid C, Cerny-Reiterer S, Krieger O, Loosdrecht AVD, Kern W, Ogata K, Wimazal F, Csomor J, Varkonyi J, Sperr WR, Werner M, Kreipe H, Horny HP (2010) Standards and impact of hematopathology in myelodysplastic syndromes (MDS). Oncotarget 1:483\u2013496","journal-title":"Oncotarget"},{"key":"1945_CR14","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","volume":"25","author":"L Malcovati","year":"2007","unstructured":"Malcovati L, Germing U, Kuendgen A et al (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evaluation in myelodysplastic syndromes. J Clin Oncol 25:3503\u20133510","journal-title":"J Clin Oncol"},{"key":"1945_CR15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","volume":"31","author":"P Valent","year":"2007","unstructured":"Valent P, Horny HP, Bennet JM, Fonatsch C, Germing U, Greenberg P et al (2007) Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from working conference. Leuk Res 31:727\u2013736","journal-title":"Leuk Res"},{"key":"1945_CR16","first-page":"1128","volume":"90","author":"J Thiele","year":"2005","unstructured":"Thiele J, Kvasnicka HM, Facchetti F et al (2005) European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 90:1128\u20131132","journal-title":"Haematologica"},{"key":"1945_CR17","unstructured":"Brunning R, Orazi A, Germing U et al (2008) Myelodysplastic syndromes, chapter 5. In: Swerdlow S, Campo E, Harris NL et al (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissue, 4th edition. IARC, Lyon, pp 88\u2013103"},{"issue":"89","key":"1945_CR18","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"1997","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau M et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997(89):2079\u20132088","journal-title":"Blood"},{"key":"1945_CR19","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2011.044602","volume":"96","author":"L Malcovati","year":"2011","unstructured":"Malcovati L, Della Porta MG, Strupp C et al (2011) Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS). Haematologica 96:1433\u20131440","journal-title":"Haematologica"},{"issue":"12","key":"1945_CR20","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J et al (2012) Revised International Prognostic Scoring System for myelodysplastic syndromes (IPSS-R). Blood 120(12):2454\u20132465","journal-title":"Blood"},{"issue":"13","key":"1945_CR21","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","volume":"113","author":"F Cervantes","year":"2009","unstructured":"Cervantes F, Dupriez B, Pereira A et al (2009) New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment. Blood 113(13):2895\u20132901","journal-title":"Blood"},{"key":"1945_CR22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","volume":"30","author":"J Schanz","year":"2012","unstructured":"Schanz J, T\u00fcchler H, Sole F et al (2012) New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol 30:820\u2013829","journal-title":"J Clin Oncol"},{"key":"1945_CR23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.leu.2404231","volume":"20","author":"M Kremer","year":"2006","unstructured":"Kremer M, Horn T, Dechow T et al (2006) The JAK2 V617F mutation occurs frequently in myelodysplastic \/ myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis. Leukemia 20:1315\u20131316","journal-title":"Leukemia"},{"issue":"2","key":"1945_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12308-008-0014-8","volume":"1","author":"RJ Olsen","year":"2008","unstructured":"Olsen RJ, Dunphy CH, O\u2019Malley DP et al (2008) The implication of identifying JAK 2 (V617F) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis. J Hematop 1(2):111\u2013117","journal-title":"J Hematop"},{"key":"1945_CR25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2141.2001.02783.x","volume":"113","author":"R Fritsche-Polanz","year":"2001","unstructured":"Fritsche-Polanz R, Jordan JH, Feix A et al (2001) Mutation analysis of c-kit in patients with myelodysplastic syndromes without mastocytosis and cases of systemic mastocytosis. Br J Haematol 113:357\u2013364","journal-title":"Br J Haematol"},{"issue":"1","key":"1945_CR26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2353\/jmoldx.2008.070061","volume":"10","author":"K Sotlar","year":"2008","unstructured":"Sotlar K, Bache A, Stellmacher F et al (2008) Systemic mastocytosis associated with chronic idiopathic myelofibrosis. J Mol Diagn 10(1):58\u201366","journal-title":"J Mol Diagn"},{"key":"1945_CR27","unstructured":"R Development Core Team, R Foundation for Statistical Computing (2009) R: a language and environment for statistical computing [Internet]. Vienna [cited 2009 Apr 17]. Available from: http:\/\/www.r-project.org\/"},{"key":"1945_CR28","unstructured":"Therneau TM, Lumley T (2009) Survival analysis, including penalised likelihood, original report by Thomas Lumley [Internet] [cited 2009 Apr 17]. Available from: http:\/\/www.r-project.org\/"},{"key":"1945_CR29","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1182\/blood-2005-03-1183","volume":"106","author":"DP Steensma","year":"2005","unstructured":"Steensma DP, Dewald GW, Lasho TL et al (2005) The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both \u201catypical\u201d myeloproliferative disorders and myelodysplastic syndromes. Blood 106:1207\u20131209","journal-title":"Blood"},{"key":"1945_CR30","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1080\/10428190410001683688","volume":"45","author":"N Suvajdzic","year":"2004","unstructured":"Suvajdzic N, Marisavljevic D, Kraguljac N et al (2004) Acute panmyelosis with myelofibrosis: clinical, immunophenotypic and cytogenetic study of twelve cases. Leuk Lymphoma 45:1873\u20131879","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"1945_CR31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000101709","volume":"74","author":"A Orazi","year":"2007","unstructured":"Orazi A (2007) Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic \/ myeloproliferative diseases. Pathobiology 74(2):97\u2013114","journal-title":"Pathobiology"},{"key":"1945_CR32","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/leu.2008.119","volume":"22","author":"A Orazi","year":"2008","unstructured":"Orazi A, Germing U (2008) The myelodysplastic\/myeloproliferative diseases with dysplastic features. Leukemia 22:1308\u20131319","journal-title":"Leukemia"},{"key":"1945_CR33","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00277-009-0745-3","volume":"88","author":"U Bacher","year":"2009","unstructured":"Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C (2009) Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS\/MPN category. Ann Hematol 88:1207\u20131213","journal-title":"Ann Hematol"},{"key":"1945_CR34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00277-008-0483-y","volume":"87","author":"D Haase","year":"2008","unstructured":"Haase D (2008) Cytogenetic features in myelodysplastic syndromes. Ann Hematol 87:515\u2013526","journal-title":"Ann Hematol"},{"key":"1945_CR35","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","volume":"110","author":"D Haase","year":"2007","unstructured":"Haase D, Germing U, Schanz J, Pfeilst\u00f6cker M, Noesslinger T, Hildebrandt B, Kuendgen A, Luebbert M, Kunzmann R, Giagounidis AA, Aul C, Truemper L, Krieger O, Stauder R, Mueller TH, Wimazal F, Valent P, Fonatsch C, Steidl C (2007) New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 110:4385\u20134395","journal-title":"Blood"},{"key":"1945_CR36","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/sj.leu.2404196","volume":"20","author":"S-F Yip","year":"2006","unstructured":"Yip S-F, So C-C, Chan AY-Y, Liu HS-Y et al (2006) The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis. Leukemia 20:1165","journal-title":"Leukemia"},{"key":"1945_CR37","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/sj.leu.2403989","volume":"19","author":"K Ohyashiki","year":"2005","unstructured":"Ohyashiki K, Aota Y, Akahane D et al (2005) The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. Leukemia 19:2359\u20132360","journal-title":"Leukemia"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1945-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1945-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1945-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T02:40:39Z","timestamp":1596854439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1945-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,17]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1945-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,17]]}}}